by John Conrad | Apr 3, 2020 | COVID
Jim Cramer chats with outgoing Abbott Labs CEO Miles White and incoming CEO Robert Ford about the medical device maker’s development of a rapid coronavirus test that can provide results in minutes.
by John Conrad | Mar 27, 2020 | COVID
Abbott (NYSE: ABT) announced today that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for the fastest available molecular point-of-care test for the detection of novel coronavirus (COVID-19), delivering positive results in as...
by John Conrad | Mar 16, 2020 | COVID, COVIDFDA
Today, as part of our ongoing and aggressive commitment to address the coronavirus outbreak, the FDA updated a policy originally issued on Feb. 29 on diagnostic testing for coronavirus (COVID-19) in order to achieve more rapid testing capacity in the U.S. We believe...
by John Conrad | Mar 12, 2020 | COVID, Member News
Advaite, an innovative biotech company focused on developing novel diagnostics, announced today that it will begin supplying the global market with its COVID-19 rapid response diagnostic testing kits, ADVAITE RAPCOV, to help efforts to contain the spread of COVID-19...
